Compound PIK3CA mutations support a mutational dose-response model for oncogene activation and response to PI3K inhibitor targeted therapy in breast cancer Meeting Abstract
| Authors: | Vasan, N.; Johnson, J.; Shao, H.; Razavi, P.; Gorelick, A.; Ladewig, E.; Antoine, A.; Shah, H.; Toska, E.; Xu, G.; Kazmi, A.; Taylor, B.; Jhaveri, K.; Dickler, M.; de Stanchina, E.; Reznik, E.; Rabadan, R.; Smith, M.; Sebra, R.; Cantley, L.; Scaltriti, M.; Baselga, J. |
| Abstract Title: | Compound PIK3CA mutations support a mutational dose-response model for oncogene activation and response to PI3K inhibitor targeted therapy in breast cancer |
| Meeting Title: | AACR Special Conference on Targeting PI3K/mTOR Signaling |
| Journal Title: | Molecular Cancer Research |
| Volume: | 18 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Nov 30-Dec 3 |
| Meeting Location: | Boston, MA |
| ISSN: | 1541-7786 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-10-01 |
| Start Page: | 38 |
| Language: | English |
| ACCESSION: | WOS:000576804500048 |
| PROVIDER: | wos |
| DOI: | 10.1158/1557-3125.PI3K-mTOR18-A21 |
| Notes: | Meeting Abstract: A21 -- Source: Wos |
